Zed’s dead, baby, Zed’s dead. And for the most part, so are those small-cap investor roadshows, who’s sponsor fill their prospective clients with the promise of analyst exposure and investor interest, only to find their stocks falling flat, despite the five digit expense paid to these so-called exposure specialists. Need first-hand proof, look at the … Read more
Cellceutics Corp (OTCMKTS: CTIX) Cellceutix is having a pretty good day in the market today. At the opening bell, the stock was trading slightly in the green before spiking upward. While the stock has corrected a bit since then, it is still trading on decent gains. Below, we’ll talk about what we’re seeing from CTIX, … Read more
Time after time, I get persuaded to check out yet another one of Adam Feuersteins pseudo intellectual posts that take issue with any small biotech company working to develop innovative and cutting edge science. While I have often asked him to opine on the perennial penny stock, TST (his parent company), he seems to deflect … Read more
Cellceutix Corp (OTCMKTS: CTIX) Cellceutix (CTIX) was the latest victim of noted short seller Mako Research, which appears to be going through their ordinary rounds of fallacious attacks, picking on the same companies in a rotary fashion, grabbing pennies when it can. But, is their style and grandeur starting to get long in the tooth … Read more
Cellceutix Corp (OTCMKTS: CTIX) Cellceutix has been an ongoing poster child for the Bully Beatdown analysis. For months now, CTIX can’t seem to catch a break on any bit of good news, with the stock sitting uncomfortably at $1.16 a share, far lower than the when I bought it about a year ago when the … Read more